In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Venture Capital: The Mature Years

Executive Summary

The maturation of the medical industry proceeds apace and with it the venture capital industry, which, paradoxically, is turning into a mature asset class. VCs don't generally recognize this--but will have to adapt their strategies to this changing reality.

You may also be interested in...

In Tough Times, VCs Go Late-Stage

Tough times in the investment business are as likely to cause unreasonably conservative behavior as much as good times might drive irrational exuberance. But for VCs, the new conservatism threatens their essential advantage as investors.

Coronavirus Update: US Public Confidence In COVID-19 Vaccines Declines

Confidence in the vaccine has slipped in the US, regardless of political affiliation.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts